Based on the measurements of operating efficiency obtained from AMERISAFE's historical financial statements, AMERISAFE is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in December. At this time, AMERISAFE's Property Plant And Equipment Net is most likely to decrease significantly in the upcoming years. The AMERISAFE's current Retained Earnings is estimated to increase to about 152.8 M, while Net Debt is projected to decrease to (40.6 M). Key indicators impacting AMERISAFE's financial strength include:
Investors should never underestimate AMERISAFE's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor AMERISAFE's cash flow, debt, and profitability to make informed and accurate decisions about investing in AMERISAFE.
Net Income
47.87 Million
AMERISAFE
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Price Earnings Ratio
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Operating Cycle
Cash Conversion Cycle
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Other Cashflows From Investing Activities
Sale Purchase Of Stock
Change To Inventory
Dividends Paid
Investments
Change Receivables
Net Borrowings
Total Cashflows From Investing Activities
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Netincome
Change To Liabilities
Change To Operating Activities
Total Assets
Short Long Term Debt Total
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Cash And Short Term Investments
Net Receivables
Common Stock Shares Outstanding
Short Term Investments
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Cash
Other Current Liab
Total Current Liabilities
Other Liab
Accounts Payable
Long Term Debt
Common Stock Total Equity
Accumulated Other Comprehensive Income
Common Stock
Property Plant Equipment
Other Current Assets
Treasury Stock
Net Tangible Assets
Good Will
Retained Earnings Total Equity
Long Term Debt Total
Capital Surpluse
Inventory
Long Term Investments
Non Current Liabilities Other
Intangible Assets
Short Term Debt
Net Invested Capital
Capital Stock
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Total Operating Expenses
Income Tax Expense
Income Before Tax
Total Other Income Expense Net
Cost Of Revenue
Net Income Applicable To Common Shares
Selling And Marketing Expenses
Net Income From Continuing Ops
Tax Provision
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past AMERISAFE Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AMERISAFE's financial statements are interrelated, with each one affecting the others. For example, an increase in AMERISAFE's assets may result in an increase in income on the income statement.
AMERISAFE competes with Assured Guaranty, MBIA, Enact Holdings, ICC Holdings, and James River. AMERISAFE, Inc., an insurance holding company, underwrites workers compensation insurance in the United States. The company was incorporated in 1985 and is based in DeRidder, Louisiana. Amerisafe operates under InsuranceSpecialty classification in the United States and is traded on NASDAQ Exchange. It employs 371 people.
Comparative valuation techniques use various fundamental indicators to help in determining AMERISAFE's current stock value. Our valuation model uses many indicators to compare AMERISAFE value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AMERISAFE competition to find correlations between indicators driving AMERISAFE's intrinsic value. More Info.
AMERISAFE is number one stock in return on equity category among its peers. It is rated fifth in return on asset category among its peers reporting about 0.20 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for AMERISAFE is roughly 5.05 . At this time, AMERISAFE's Return On Equity is most likely to increase slightly in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value AMERISAFE by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
AMERISAFE Systematic Risk
AMERISAFE's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AMERISAFE volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on AMERISAFE correlated with the market. If Beta is less than 0 AMERISAFE generally moves in the opposite direction as compared to the market. If AMERISAFE Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AMERISAFE is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AMERISAFE is generally in the same direction as the market. If Beta > 1 AMERISAFE moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in AMERISAFE Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AMERISAFE's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of AMERISAFE growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of AMERISAFE help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AMERISAFE. We use our internally-developed statistical techniques to arrive at the intrinsic value of AMERISAFE based on widely used predictive technical indicators. In general, we focus on analyzing AMERISAFE Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AMERISAFE's daily price indicators and compare them against related drivers.
When running AMERISAFE's price analysis, check to measure AMERISAFE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AMERISAFE is operating at the current time. Most of AMERISAFE's value examination focuses on studying past and present price action to predict the probability of AMERISAFE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AMERISAFE's price. Additionally, you may evaluate how the addition of AMERISAFE to your portfolios can decrease your overall portfolio volatility.